nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—SLC25A4—peripheral nervous system—migraine	0.0536	0.146	CbGeAlD
Clodronate—SLC25A4—Synaptic Vesicle Pathway—ATP1A2—migraine	0.0337	0.116	CbGpPWpGaD
Clodronate—SLC25A6—neck—migraine	0.0288	0.0782	CbGeAlD
Clodronate—SLC25A5—Regulation of insulin secretion—CACNA1A—migraine	0.0268	0.0921	CbGpPWpGaD
Clodronate—SLC25A5—neck—migraine	0.0251	0.0681	CbGeAlD
Clodronate—SLC25A4—Synaptic Vesicle Pathway—CACNA1A—migraine	0.0244	0.0838	CbGpPWpGaD
Clodronate—SLC25A6—Regulation of insulin secretion—CACNA1A—migraine	0.0225	0.0772	CbGpPWpGaD
Clodronate—SLC25A6—brainstem—migraine	0.022	0.0598	CbGeAlD
Clodronate—SLC25A5—trigeminal ganglion—migraine	0.0216	0.0588	CbGeAlD
Clodronate—SLC25A5—Integration of energy metabolism—CACNA1A—migraine	0.0211	0.0724	CbGpPWpGaD
Clodronate—SLC25A6—cardiovascular system—migraine	0.018	0.0488	CbGeAlD
Clodronate—SLC25A6—Integration of energy metabolism—CACNA1A—migraine	0.0177	0.0607	CbGpPWpGaD
Clodronate—SLC25A4—Regulation of insulin secretion—CACNA1A—migraine	0.0175	0.0603	CbGpPWpGaD
Clodronate—SLC25A4—Alprenolol—Propranolol—migraine	0.0168	1	CbGdCrCtD
Clodronate—SLC25A5—cardiovascular system—migraine	0.0156	0.0425	CbGeAlD
Clodronate—SLC25A4—cardiovascular system—migraine	0.0146	0.0398	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—ATP1A3—migraine	0.0138	0.0474	CbGpPWpGaD
Clodronate—SLC25A4—Integration of energy metabolism—CACNA1A—migraine	0.0138	0.0474	CbGpPWpGaD
Clodronate—SLC25A4—Synaptic Vesicle Pathway—SLC6A4—migraine	0.0132	0.0452	CbGpPWpGaD
Clodronate—SLC25A6—head—migraine	0.0122	0.033	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HTR3A—migraine	0.0117	0.0403	CbGpPWpGaD
Clodronate—SLC25A6—nervous system—migraine	0.0115	0.0313	CbGeAlD
Clodronate—SLC25A6—central nervous system—migraine	0.0111	0.0302	CbGeAlD
Clodronate—SLC25A6—cerebellum—migraine	0.0109	0.0295	CbGeAlD
Clodronate—SLC25A5—head—migraine	0.0106	0.0287	CbGeAlD
Clodronate—SLC25A5—nervous system—migraine	0.01	0.0273	CbGeAlD
Clodronate—SLC25A4—head—migraine	0.00991	0.0269	CbGeAlD
Clodronate—SLC25A5—central nervous system—migraine	0.00966	0.0262	CbGeAlD
Clodronate—SLC25A5—cerebellum—migraine	0.00944	0.0256	CbGeAlD
Clodronate—SLC25A4—nervous system—migraine	0.0094	0.0255	CbGeAlD
Clodronate—SLC25A4—central nervous system—migraine	0.00905	0.0246	CbGeAlD
Clodronate—SLC25A4—cerebellum—migraine	0.00885	0.024	CbGeAlD
Clodronate—SLC25A6—brain—migraine	0.00881	0.0239	CbGeAlD
Clodronate—SLC25A5—brain—migraine	0.00767	0.0208	CbGeAlD
Clodronate—SLC25A4—brain—migraine	0.00718	0.0195	CbGeAlD
Clodronate—PTGS2—blood vessel—migraine	0.00659	0.0179	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HTR1A—migraine	0.00557	0.0192	CbGpPWpGaD
Clodronate—Cardiac failure—Verapamil—migraine	0.00552	0.017	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TAC1—migraine	0.00549	0.0189	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—SLC6A4—migraine	0.00538	0.0185	CbGpPWpGaD
Clodronate—Bronchospasm—Propranolol—migraine	0.00498	0.0154	CcSEcCtD
Clodronate—Creatinine increased—Gabapentin—migraine	0.00458	0.0141	CcSEcCtD
Clodronate—Bronchospasm—Verapamil—migraine	0.00458	0.0141	CcSEcCtD
Clodronate—Hepatic function abnormal—Valproic Acid—migraine	0.00437	0.0135	CcSEcCtD
Clodronate—PTGS2—trigeminal ganglion—migraine	0.00407	0.0111	CbGeAlD
Clodronate—Pharyngitis—Propranolol—migraine	0.00402	0.0124	CcSEcCtD
Clodronate—Hypocalcaemia—Topiramate—migraine	0.00401	0.0124	CcSEcCtD
Clodronate—Oliguria—Topiramate—migraine	0.00398	0.0123	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—BDNF—migraine	0.00391	0.0134	CbGpPWpGaD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00387	0.0133	CbGpPWpGaD
Clodronate—Creatinine increased—Topiramate—migraine	0.00386	0.0119	CcSEcCtD
Clodronate—Pharyngitis—Verapamil—migraine	0.0037	0.0114	CcSEcCtD
Clodronate—Hepatic function abnormal—Gabapentin—migraine	0.00362	0.0112	CcSEcCtD
Clodronate—Abdominal pain upper—Valproic Acid—migraine	0.00349	0.0108	CcSEcCtD
Clodronate—Cardiac failure—Timolol—migraine	0.00348	0.0107	CcSEcCtD
Clodronate—Renal failure acute—Gabapentin—migraine	0.00343	0.0106	CcSEcCtD
Clodronate—Anorexia—Amitriptyline—migraine	0.00337	0.0104	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Valproic Acid—migraine	0.00337	0.0104	CcSEcCtD
Clodronate—Renal impairment—Gabapentin—migraine	0.00333	0.0103	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HTR2A—migraine	0.0033	0.0113	CbGpPWpGaD
Clodronate—Dysphagia—Valproic Acid—migraine	0.0033	0.0102	CcSEcCtD
Clodronate—Cardiac failure—Gabapentin—migraine	0.00324	0.01	CcSEcCtD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00323	0.0111	CbGpPWpGaD
Clodronate—Dyspepsia—Amitriptyline—migraine	0.00311	0.0096	CcSEcCtD
Clodronate—Abdominal pain upper—Timolol—migraine	0.00311	0.00958	CcSEcCtD
Clodronate—Decreased appetite—Amitriptyline—migraine	0.00307	0.00948	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00298	0.0092	CcSEcCtD
Clodronate—Blood creatinine increased—Gabapentin—migraine	0.00297	0.00915	CcSEcCtD
Clodronate—Angioedema—Verapamil—migraine	0.00296	0.00915	CcSEcCtD
Clodronate—Pneumonia—Valproic Acid—migraine	0.00296	0.00913	CcSEcCtD
Clodronate—Dehydration—Gabapentin—migraine	0.00294	0.00909	CcSEcCtD
Clodronate—PTGS2—cardiovascular system—migraine	0.00294	0.00799	CbGeAlD
Clodronate—Bronchospasm—Timolol—migraine	0.00289	0.00892	CcSEcCtD
Clodronate—Infection—Propranolol—migraine	0.00286	0.00882	CcSEcCtD
Clodronate—Urticaria—Amitriptyline—migraine	0.00281	0.00866	CcSEcCtD
Clodronate—Skin disorder—Propranolol—migraine	0.0028	0.00863	CcSEcCtD
Clodronate—Dysphagia—Gabapentin—migraine	0.00274	0.00844	CcSEcCtD
Clodronate—Bronchospasm—Gabapentin—migraine	0.00269	0.00831	CcSEcCtD
Clodronate—Infection—Verapamil—migraine	0.00263	0.00812	CcSEcCtD
Clodronate—Pharyngitis—Valproic Acid—migraine	0.00262	0.00809	CcSEcCtD
Clodronate—Urinary tract disorder—Valproic Acid—migraine	0.00261	0.00805	CcSEcCtD
Clodronate—Connective tissue disorder—Valproic Acid—migraine	0.0026	0.00801	CcSEcCtD
Clodronate—Urethral disorder—Valproic Acid—migraine	0.00259	0.00799	CcSEcCtD
Clodronate—Dyspnoea—Propranolol—migraine	0.00257	0.00792	CcSEcCtD
Clodronate—Dyspepsia—Propranolol—migraine	0.00253	0.00782	CcSEcCtD
Clodronate—Decreased appetite—Propranolol—migraine	0.0025	0.00772	CcSEcCtD
Clodronate—Pruritus—Amitriptyline—migraine	0.0025	0.00772	CcSEcCtD
Clodronate—Blood creatinine increased—Topiramate—migraine	0.0025	0.0077	CcSEcCtD
Clodronate—Gastrointestinal disorder—Propranolol—migraine	0.00249	0.00767	CcSEcCtD
Clodronate—Dehydration—Topiramate—migraine	0.00248	0.00764	CcSEcCtD
Clodronate—Pneumonia—Gabapentin—migraine	0.00245	0.00757	CcSEcCtD
Clodronate—Abdominal pain upper—Topiramate—migraine	0.00243	0.00751	CcSEcCtD
Clodronate—Diarrhoea—Amitriptyline—migraine	0.00242	0.00746	CcSEcCtD
Clodronate—SLC25A5—Metabolism—CACNA1A—migraine	0.00241	0.00828	CbGpPWpGaD
Clodronate—Renal failure—Gabapentin—migraine	0.0024	0.0074	CcSEcCtD
Clodronate—Mediastinal disorder—Valproic Acid—migraine	0.00238	0.00735	CcSEcCtD
Clodronate—Dyspnoea—Verapamil—migraine	0.00236	0.00728	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Topiramate—migraine	0.00235	0.00725	CcSEcCtD
Clodronate—Dyspepsia—Verapamil—migraine	0.00233	0.00719	CcSEcCtD
Clodronate—Connective tissue disorder—Timolol—migraine	0.00231	0.00713	CcSEcCtD
Clodronate—Dysphagia—Topiramate—migraine	0.0023	0.0071	CcSEcCtD
Clodronate—Urticaria—Propranolol—migraine	0.00229	0.00705	CcSEcCtD
Clodronate—Abdominal pain—Propranolol—migraine	0.00228	0.00702	CcSEcCtD
Clodronate—SLC25A5—Disease—LRP1—migraine	0.00226	0.00776	CbGpPWpGaD
Clodronate—Vomiting—Amitriptyline—migraine	0.00225	0.00693	CcSEcCtD
Clodronate—Rash—Amitriptyline—migraine	0.00223	0.00688	CcSEcCtD
Clodronate—Dermatitis—Amitriptyline—migraine	0.00223	0.00687	CcSEcCtD
Clodronate—Pharyngitis—Gabapentin—migraine	0.00217	0.00671	CcSEcCtD
Clodronate—Urinary tract disorder—Gabapentin—migraine	0.00216	0.00667	CcSEcCtD
Clodronate—Connective tissue disorder—Gabapentin—migraine	0.00215	0.00664	CcSEcCtD
Clodronate—Urethral disorder—Gabapentin—migraine	0.00215	0.00663	CcSEcCtD
Clodronate—Anaemia—Valproic Acid—migraine	0.00213	0.00656	CcSEcCtD
Clodronate—Mediastinal disorder—Timolol—migraine	0.00212	0.00654	CcSEcCtD
Clodronate—Urticaria—Verapamil—migraine	0.0021	0.00649	CcSEcCtD
Clodronate—Angioedema—Valproic Acid—migraine	0.0021	0.00648	CcSEcCtD
Clodronate—Nausea—Amitriptyline—migraine	0.0021	0.00648	CcSEcCtD
Clodronate—Pneumonia—Topiramate—migraine	0.00206	0.00637	CcSEcCtD
Clodronate—SLC25A6—Metabolism—CACNA1A—migraine	0.00202	0.00694	CbGpPWpGaD
Clodronate—Renal failure—Topiramate—migraine	0.00202	0.00623	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.00201	0.00689	CbGpPWpGaD
Clodronate—PTGS2—head—migraine	0.00199	0.00541	CbGeAlD
Clodronate—Mediastinal disorder—Gabapentin—migraine	0.00197	0.00609	CcSEcCtD
Clodronate—Diarrhoea—Propranolol—migraine	0.00197	0.00608	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00194	0.006	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—ACE—migraine	0.00194	0.00668	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.00192	0.00658	CbGpPWpGaD
Clodronate—SLC25A6—Disease—LRP1—migraine	0.00189	0.0065	CbGpPWpGaD
Clodronate—PTGS2—nervous system—migraine	0.00189	0.00513	CbGeAlD
Clodronate—Pruritus—Verapamil—migraine	0.00187	0.00578	CcSEcCtD
Clodronate—Angioedema—Timolol—migraine	0.00187	0.00577	CcSEcCtD
Clodronate—Infection—Valproic Acid—migraine	0.00187	0.00575	CcSEcCtD
Clodronate—Vomiting—Propranolol—migraine	0.00183	0.00565	CcSEcCtD
Clodronate—Pharyngitis—Topiramate—migraine	0.00183	0.00564	CcSEcCtD
Clodronate—Skin disorder—Valproic Acid—migraine	0.00182	0.00563	CcSEcCtD
Clodronate—Urinary tract disorder—Topiramate—migraine	0.00182	0.00562	CcSEcCtD
Clodronate—PTGS2—central nervous system—migraine	0.00182	0.00494	CbGeAlD
Clodronate—Rash—Propranolol—migraine	0.00181	0.0056	CcSEcCtD
Clodronate—Dermatitis—Propranolol—migraine	0.00181	0.00559	CcSEcCtD
Clodronate—Diarrhoea—Verapamil—migraine	0.00181	0.00559	CcSEcCtD
Clodronate—Connective tissue disorder—Topiramate—migraine	0.00181	0.00559	CcSEcCtD
Clodronate—Urethral disorder—Topiramate—migraine	0.00181	0.00557	CcSEcCtD
Clodronate—Anorexia—Valproic Acid—migraine	0.00179	0.00552	CcSEcCtD
Clodronate—PTGS2—cerebellum—migraine	0.00178	0.00483	CbGeAlD
Clodronate—Anaemia—Gabapentin—migraine	0.00176	0.00544	CcSEcCtD
Clodronate—Angioedema—Gabapentin—migraine	0.00174	0.00538	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00173	0.00534	CcSEcCtD
Clodronate—Nausea—Propranolol—migraine	0.00171	0.00527	CcSEcCtD
Clodronate—Vomiting—Verapamil—migraine	0.00168	0.00519	CcSEcCtD
Clodronate—Dyspnoea—Valproic Acid—migraine	0.00167	0.00516	CcSEcCtD
Clodronate—Rash—Verapamil—migraine	0.00167	0.00515	CcSEcCtD
Clodronate—Dermatitis—Verapamil—migraine	0.00167	0.00515	CcSEcCtD
Clodronate—Mediastinal disorder—Topiramate—migraine	0.00166	0.00512	CcSEcCtD
Clodronate—Infection—Timolol—migraine	0.00166	0.00512	CcSEcCtD
Clodronate—Dyspepsia—Valproic Acid—migraine	0.00165	0.0051	CcSEcCtD
Clodronate—Decreased appetite—Valproic Acid—migraine	0.00163	0.00504	CcSEcCtD
Clodronate—Skin disorder—Timolol—migraine	0.00162	0.00501	CcSEcCtD
Clodronate—Gastrointestinal disorder—Valproic Acid—migraine	0.00162	0.005	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00161	0.00497	CcSEcCtD
Clodronate—Anorexia—Timolol—migraine	0.00159	0.00492	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CACNA1A—migraine	0.00158	0.00542	CbGpPWpGaD
Clodronate—Nausea—Verapamil—migraine	0.00157	0.00485	CcSEcCtD
Clodronate—Infection—Gabapentin—migraine	0.00155	0.00477	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.00154	0.00529	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—ACE—migraine	0.00152	0.00521	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.00151	0.0052	CbGpPWpGaD
Clodronate—Skin disorder—Gabapentin—migraine	0.00151	0.00466	CcSEcCtD
Clodronate—Urticaria—Valproic Acid—migraine	0.00149	0.0046	CcSEcCtD
Clodronate—Dyspnoea—Timolol—migraine	0.00149	0.0046	CcSEcCtD
Clodronate—Abdominal pain—Valproic Acid—migraine	0.00148	0.00458	CcSEcCtD
Clodronate—Anorexia—Gabapentin—migraine	0.00148	0.00458	CcSEcCtD
Clodronate—Anaemia—Topiramate—migraine	0.00148	0.00457	CcSEcCtD
Clodronate—SLC25A4—Disease—LRP1—migraine	0.00148	0.00508	CbGpPWpGaD
Clodronate—Dyspepsia—Timolol—migraine	0.00147	0.00454	CcSEcCtD
Clodronate—SLC25A5—Disease—CALCA—migraine	0.00146	0.005	CbGpPWpGaD
Clodronate—Decreased appetite—Timolol—migraine	0.00145	0.00448	CcSEcCtD
Clodronate—PTGS2—brain—migraine	0.00144	0.00392	CbGeAlD
Clodronate—Gastrointestinal disorder—Timolol—migraine	0.00144	0.00445	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—migraine	0.00142	0.00488	CbGpPWpGaD
Clodronate—Dyspnoea—Gabapentin—migraine	0.00139	0.00428	CcSEcCtD
Clodronate—Dyspepsia—Gabapentin—migraine	0.00137	0.00423	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00136	0.00419	CcSEcCtD
Clodronate—Decreased appetite—Gabapentin—migraine	0.00135	0.00417	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gabapentin—migraine	0.00134	0.00415	CcSEcCtD
Clodronate—Pruritus—Valproic Acid—migraine	0.00133	0.0041	CcSEcCtD
Clodronate—Urticaria—Timolol—migraine	0.00133	0.0041	CcSEcCtD
Clodronate—Abdominal pain—Timolol—migraine	0.00132	0.00408	CcSEcCtD
Clodronate—Infection—Topiramate—migraine	0.0013	0.00401	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.0013	0.00446	CbGpPWpGaD
Clodronate—Diarrhoea—Valproic Acid—migraine	0.00128	0.00396	CcSEcCtD
Clodronate—Skin disorder—Topiramate—migraine	0.00127	0.00392	CcSEcCtD
Clodronate—Anorexia—Topiramate—migraine	0.00125	0.00385	CcSEcCtD
Clodronate—Urticaria—Gabapentin—migraine	0.00124	0.00381	CcSEcCtD
Clodronate—Abdominal pain—Gabapentin—migraine	0.00123	0.0038	CcSEcCtD
Clodronate—SLC25A6—Disease—CALCA—migraine	0.00122	0.00419	CbGpPWpGaD
Clodronate—Vomiting—Valproic Acid—migraine	0.00119	0.00368	CcSEcCtD
Clodronate—Rash—Valproic Acid—migraine	0.00118	0.00365	CcSEcCtD
Clodronate—Dermatitis—Valproic Acid—migraine	0.00118	0.00365	CcSEcCtD
Clodronate—Pruritus—Timolol—migraine	0.00118	0.00365	CcSEcCtD
Clodronate—SLC25A5—Disease—TGFBR2—migraine	0.00117	0.00403	CbGpPWpGaD
Clodronate—Dyspnoea—Topiramate—migraine	0.00117	0.0036	CcSEcCtD
Clodronate—Dyspepsia—Topiramate—migraine	0.00115	0.00356	CcSEcCtD
Clodronate—Diarrhoea—Timolol—migraine	0.00114	0.00353	CcSEcCtD
Clodronate—Decreased appetite—Topiramate—migraine	0.00114	0.00351	CcSEcCtD
Clodronate—Gastrointestinal disorder—Topiramate—migraine	0.00113	0.00349	CcSEcCtD
Clodronate—Nausea—Valproic Acid—migraine	0.00112	0.00344	CcSEcCtD
Clodronate—Pruritus—Gabapentin—migraine	0.0011	0.0034	CcSEcCtD
Clodronate—Diarrhoea—Gabapentin—migraine	0.00106	0.00329	CcSEcCtD
Clodronate—Vomiting—Timolol—migraine	0.00106	0.00328	CcSEcCtD
Clodronate—Rash—Timolol—migraine	0.00105	0.00325	CcSEcCtD
Clodronate—Dermatitis—Timolol—migraine	0.00105	0.00325	CcSEcCtD
Clodronate—Urticaria—Topiramate—migraine	0.00104	0.00321	CcSEcCtD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.00104	0.00357	CbGpPWpGaD
Clodronate—Abdominal pain—Topiramate—migraine	0.00104	0.00319	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	0.00103	0.00354	CbGpPWpGaD
Clodronate—Nausea—Timolol—migraine	0.000993	0.00306	CcSEcCtD
Clodronate—Vomiting—Gabapentin—migraine	0.00099	0.00305	CcSEcCtD
Clodronate—SLC25A6—Disease—TGFBR2—migraine	0.000982	0.00338	CbGpPWpGaD
Clodronate—Rash—Gabapentin—migraine	0.000981	0.00303	CcSEcCtD
Clodronate—Dermatitis—Gabapentin—migraine	0.00098	0.00302	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—BDNF—migraine	0.000966	0.00332	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CALCA—migraine	0.000952	0.00327	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MTHFR—migraine	0.000952	0.00327	CbGpPWpGaD
Clodronate—Pruritus—Topiramate—migraine	0.000926	0.00286	CcSEcCtD
Clodronate—Nausea—Gabapentin—migraine	0.000924	0.00285	CcSEcCtD
Clodronate—Diarrhoea—Topiramate—migraine	0.000896	0.00276	CcSEcCtD
Clodronate—Vomiting—Topiramate—migraine	0.000833	0.00257	CcSEcCtD
Clodronate—Rash—Topiramate—migraine	0.000826	0.00255	CcSEcCtD
Clodronate—Dermatitis—Topiramate—migraine	0.000825	0.00254	CcSEcCtD
Clodronate—SLC25A6—Disease—MTHFR—migraine	0.000798	0.00274	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MTHFR—migraine	0.000797	0.00274	CbGpPWpGaD
Clodronate—Nausea—Topiramate—migraine	0.000778	0.0024	CcSEcCtD
Clodronate—SLC25A4—Disease—TGFBR2—migraine	0.000767	0.00263	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	0.000746	0.00256	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000698	0.0024	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MTHFR—migraine	0.000668	0.0023	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000657	0.00226	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—FOS—migraine	0.000653	0.00224	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—migraine	0.000623	0.00214	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—migraine	0.000522	0.00179	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000493	0.00169	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—migraine	0.000444	0.00153	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—migraine	0.000351	0.00121	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CACNA1A—migraine	0.000312	0.00107	CbGpPWpGaD
Clodronate—PTGS2—Disease—LRP1—migraine	0.000292	0.001	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000239	0.00082	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALCA—migraine	0.000188	0.000647	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFBR2—migraine	0.000152	0.000521	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—migraine	0.000123	0.000423	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—migraine	0.000103	0.000354	CbGpPWpGaD
